This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Breast Carcinoma In Situ

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Breast Carcinoma In Situ Means

Breast carcinoma in situ is a condition where abnormal cells are found in the breast tissue but have not spread beyond their original location. The term “in situ” means “in place,” indicating that these cells remain confined within the ducts or skin layers where they started. There are two main types: ductal carcinoma in situ (DCIS), where abnormal cells line the milk ducts, and Paget disease of the nipple, where abnormal cells affect the skin of the nipple and sometimes the areola. Unlike invasive breast cancer, these cells have not grown into surrounding breast tissue.

Why This Condition Matters

While breast carcinoma in situ itself is not life-threatening, it is important because it may increase the risk of developing invasive breast cancer if left untreated. Detecting and treating these abnormal cells early can help prevent progression to invasive cancer. This diagnosis is often called stage 0 breast cancer, which helps doctors decide on the best treatment and follow-up care.

What Patients Might Notice or Be Told

Many people with breast carcinoma in situ do not have symptoms, and the condition is often found during routine mammograms or breast exams. In the case of Paget disease of the nipple, changes such as redness, flaking, or irritation of the nipple skin may be noticed. When this diagnosis appears in medical reports or discussions, it means abnormal cells have been found that need attention but have not spread.

How Doctors Use This Diagnosis

Doctors use the diagnosis of breast carcinoma in situ to guide treatment decisions. Because the abnormal cells have not spread, treatment usually focuses on local approaches like surgery to remove the affected area or radiation therapy to reduce the chance of progression. Systemic treatments like chemotherapy are generally not used for carcinoma in situ. This diagnosis also helps stage breast cancer as stage 0, which influences monitoring and follow-up plans.

Common Confusions and Questions

It is important to understand that breast carcinoma in situ is not the same as invasive breast cancer. The term does not mean cancer has spread or that it is immediately life-threatening. Patients and caregivers may find the terminology confusing, especially distinguishing between carcinoma in situ and invasive cancer. Asking your doctor questions like “What does this mean for my risk?” or “What treatment options do you recommend?” can help clarify your situation.

Reading the Term in Context

This term may appear in pathology reports, treatment plans, or clinical trial information. Comparing the exact wording in your medical documents can help avoid confusion, especially since related terms like DCIS or Paget disease of the nipple may also be used. Understanding the diagnosis in the context of your overall health and care plan is key to making informed decisions.

Important Safety Note

This information is educational and does not replace personalized medical advice. Each person’s situation is unique, so it is important to discuss any diagnosis or treatment plan with your healthcare team to understand what applies to you.

Next Steps for Patients and Caregivers

If you or a loved one has been told about breast carcinoma in situ, the best next step is to talk openly with your doctor about what this means for your health. Discuss recommended treatment or monitoring options and how to stay informed about your breast health going forward. Understanding this condition can help reduce worry and support you in making the best choices for your care.

Sources

Public source information used for this glossary entry includes: